Literature DB >> 21872764

Commercial cell-based therapies for musculoskeletal injuries in horses.

Santiago D Gutierrez-Nibeyro1.   

Abstract

Several cell-based therapeutic options to treat musculoskeletal injuries in horses are commercially available. The current literature supports the use of cell-based therapies to treat equine musculoskeletal injuries. Researchers continue to search for more effective cell-based therapies to provide practitioners with optimal treatment tools for musculoskeletal injuries in horses. Cell-based therapies require specialized facilities and technical competencies that might not be available or economically justifiable in many private practices. This review provides a summary of current commercially available cell-based therapeutic products for equine applications, their similarities and differences, and current objective data relating to their clinical efficacy.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21872764     DOI: 10.1016/j.cveq.2011.04.001

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  6 in total

1.  The promise of stem cell technology.

Authors:  Carlton Gyles
Journal:  Can Vet J       Date:  2012-10       Impact factor: 1.008

2.  From skeletal muscle to stem cells: an innovative and minimally-invasive process for multiple species.

Authors:  J Ceusters; J-Ph Lejeune; C Sandersen; A Niesten; L Lagneaux; D Serteyn
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

3.  Treatment of canine osteoarthritis with allogeneic platelet-rich plasma: review of five cases.

Authors:  José Catarino; Pedro Carvalho; Sara Santos; Ângela Martins; João Requicha
Journal:  Open Vet J       Date:  2020-06-30

4.  Extracorporeal Shock Wave Therapy Enhances the In Vitro Metabolic Activity and Differentiation of Equine Umbilical Cord Blood Mesenchymal Stromal Cells.

Authors:  Ramés Salcedo-Jiménez; Judith B Koenig; Olivia J Lee; Thomas W G Gibson; Pavneesh Madan; Thomas G Koch
Journal:  Front Vet Sci       Date:  2020-12-04

5.  Comparison of the efficacy of bone morphogenetic protein-4 on in vitro differentiation of murine adipose and bone marrow mesenchymal stem cells into primordial germ cells.

Authors:  Maryam Hosseinzadeh Shirzeyli; Ali Tayyebiazar; Fereshteh Aliakbari; Fahimeh Ghasemi; Fatemeh Eini; Farhad Hosseinzadeh Shirzeyli; Elmira Vanaki; Aligholi Sobhani
Journal:  Res Pharm Sci       Date:  2022-01-15

6.  Equine mesenchymal stem cells from bone marrow, adipose tissue and umbilical cord: immunophenotypic characterization and differentiation potential.

Authors:  Danielle Jaqueta Barberini; Natália Pereira Paiva Freitas; Mariana Sartori Magnoni; Leandro Maia; Amanda Jerônimo Listoni; Marta Cristina Heckler; Mateus Jose Sudano; Marjorie Assis Golim; Fernanda da Cruz Landim-Alvarenga; Rogério Martins Amorim
Journal:  Stem Cell Res Ther       Date:  2014-02-21       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.